MAIA Pharma

BORTEZOMIB (MAIA)

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

MAIA Pharma

Bortezomib (Maia) HCPCS:

J9051

HCPCS Code Descriptor:

Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg

Category:

J Code

Bortezomib (Maia) NDCs:

72266-0244-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Bortezomib (Maia) CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

72266-0244-01

About Bortezomib (Maia):

Bortezomib (Maia) is an Oncology drug manufactured by Maia and administered via the Intravenous route of administration. The J Code: J9051 is aligned to the drug Bortezomib (Maia).

ACCESS PRICING AND MORE BY REGISTERING

J9051 Added Date:

October 1, 2023

J9051 Effective Date:

October 1, 2023

J9051 Termination Date:

We have not yet identified a manufacturer source of Bortezomib (Maia) billing and coding information.
BORTEZOMIB (MAIA) prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for BORTEZOMIB (MAIA). Please check back in a few weeks.